Gapping up
Select oil/gas related names showing strength:
- USO +3.8%, WTI +3.6%, SHEL +2.7%, KOS +2.7%, SLB +2.4%, HAL +2.3%, OIH +2.1%, BP +2%, XLE +1.9%, MUR +1.8%, XOM +1.5%, PSX +1.5%
Other news:
- PLAN +28.6% (to be acquired by Thoma Bravo for $66.00 per share)
- GES +3.7% (entered into an accelerated share repurchase agreement to repurchase $175 mln of its common stock)
- MCG +2.8% (authorizes stock repurchase program to repurchase up to $50 mln of the Company's Class A common stock)
- SRNE +2.3% (reports promising results with a universal chimeric mRNA COVID-19 Vaccine that elicits potent neutralizing antibodies and protection against Omicron and Delta Variants)
- PRVB +1.5% (FDA accepts BLA resubmission for teplizumab for the delay of clinical type 1 diabetes)
- CGEN +1.5% (Compugen's computational discovery leverages single cell spatial transcriptomics to gain in-depth understanding of the tumor microenvironment)
- PW +1.4% (agrees to fund energy efficiency improvements at its greenhouse in York County, Maine) .
Analyst comments:
- DUOL +3.5% (upgraded to Overweight from Sector Weight at KeyBanc Capital Markets)
- BB +1.8% (upgraded to Sector Perform from Underperform at RBC Capital Mkts)
- APD +1.6% (upgraded to Overweight from Neutral at JP Morgan)
- ASB +1.2% (upgraded to Overweight from Equal Weight at Wells Fargo)
- AWI +1.1% (upgraded to Buy from Hold at Jefferies)